Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-28

Clinical Trial Update: Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection [Phase 1]

View source ↗

Summary

Phase 1 study evaluating drug-drug interaction between bexagliflozin and exenatide injection in type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bexagliflozin (null)
  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: Theracos | Conditions: Type2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2021-05-28